KINN THERAPEUTICS AS

5021 BERGEN

Finances

Share Ownership

Return on Equity

−186,22 %

Current Ratio

2,31

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	1 620 000	1 072 000	3 983 000	4 381 000
Net Income	−743 000	−1 642 000	1 324 000	766 000
Total Assets	697 000	1 507 000	3 116 000	1 798 000
Total Equity	399 000	1 142 000	2 784 000	1 460 000

Income (NOK)	2022	2021	2020	2019
Revenue	1 620 000	1 072 000	3 983 000	4 381 000
Expenditure	2 361 000	2 712 000	2 634 000	3 616 000
Operating Profit	−741 000	−1 640 000	1 349 000	765 000
Financial Income	0	0	1 000	1 000
Financial Costs	2 000	2 000	1 000	0
Financial Balance	−2 000	−2 000	0	1 000
Earnings Before Tax	−743 000	−1 642 000	1 350 000	766 000
Tax	0	0	26 000	0
Net Income	−743 000	−1 642 000	1 324 000	766 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	10 000	74 000	170 000	227 000
Total Current Assets	687 000	1 434 000	2 946 000	1 571 000
Total Assets	697 000	1 507 000	3 116 000	1 798 000
Total Retained Equity	294 000	1 037 000	2 679 000	1 355 000
Total Equity	399 000	1 142 000	2 784 000	1 460 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	298 000	365 000	332 000	338 000
Total Equity and Debt	697 000	1 507 000	3 116 000	1 798 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	1 620 000	896 000	3 983 000	4 381 000
Other Income	0	176 000	0	0
Revenue	1 620 000	1 072 000	3 983 000	4 381 000
Cost of Goods Sold	265 000	41 000	430 000	875 000
Salary Costs	1 938 000	2 467 000	2 024 000	2 555 000
Depreciation	64 000	97 000	87 000	64 000
Impairment	0	0	0	0
Expenditure	2 361 000	2 712 000	2 634 000	3 616 000
Operating Profit	−741 000	−1 640 000	1 349 000	765 000
Financial Income	0	0	1 000	1 000
Financial Costs	2 000	2 000	1 000	0
Financial Balance	−2 000	−2 000	0	1 000
Dividends	0	0	0	0
Net Income	−743 000	−1 642 000	1 324 000	766 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	10 000	74 000	170 000	227 000
Total Tangible Assets	10 000	74 000	170 000	227 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	10 000	74 000	170 000	227 000
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	632 000	1 428 000	2 924 000	1 282 000
Total Current Assets	687 000	1 434 000	2 946 000	1 571 000
Total Assets	697 000	1 507 000	3 116 000	1 798 000
Total Equity	399 000	1 142 000	2 784 000	1 460 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	0	0
Creditors	7 000	3 000	−1 000	6 000
Unpaid Taxes	150 000	212 000	148 000	129 000
Dividends	0	0	0	0
Other Current Debt	140 000	150 000	160 000	202 000
Total Current Debt	298 000	365 000	332 000	338 000
Total Equity and Debt	697 000	1 507 000	3 116 000	1 798 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−186,22 %	−143,78 %	47,56 %	52,47 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	−45,74 %	−152,99 %	33,87 %	17,46 %
Current Ratio	2,31	3,93	8,87	4,65
Quick Ratio	2,31	3,93	8,87	4,65
Equity Ratio	0,57	0,76	0,89	0,81
Gross Profit Margin	83,64 %	96,18 %	89,2 %	80,03 %